Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0006 Transporter Info | ||||
Gene Name | SLC22A2 | ||||
Transporter Name | Organic cation transporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
TCF4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC22A2 gene in glioblastoma multiforme condition | [1] | ||||
TF Protein Name |
Transcription factor 4 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Temozolomide | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor 4 (TCF4) has been reported to bind to the transcription of SLC22A2 gene in glioblastoma multiforme condition, which leads to an affected expression of the drug transporter Organic cation transporter 2. | |||||
USF1 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC22A2 gene in health condition | [2] | ||||
TF Protein Name |
Upstream stimulatory factor 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Upstream stimulatory factor 1 (USF1) has been reported to bind to the transcription of SLC22A2 gene in health condition, which leads to an affected expression of the drug transporter Organic cation transporter 2. | |||||
Transcriptional Phenomenon2 |
Activation of SLC22A2 gene in health condition | [3] | ||||
TF Protein Name |
Upstream stimulatory factor 1 | Transcription Factor Info | ||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Pig Kidney epithelial cells (LLC-PK1) | |||||
Detailed Description |
Upstream stimulatory factor 1 (USF1) has been reported to activate the transcription of SLC22A2 gene in health condition, which leads to an increased expression of the drug transporter Organic cation transporter 2. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
AR |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC22A2 gene | [4] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC22A2 gene in . condition, which leads to a affected expression of the drug transporter Organic cation transporter 2. | |||||
Transcriptional Phenomenon2 |
Binding to SLC22A2 gene in prostate cancer condition | [5] | ||||
TF Protein Name |
Androgen receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Androgen receptor (AR) has been reported to bind to the transcription of SLC22A2 gene in prostate cancer condition, which leads to an affected expression of the drug transporter Organic cation transporter 2. | |||||
HNF4A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC22A2 gene in health condition | [6] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SLC22A2 gene in health condition, which leads to an affected expression of the drug transporter Organic cation transporter 2. | |||||
NR3C1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC22A2 gene in ER(-) breast cancer condition | [7] | ||||
TF Protein Name |
Glucocorticoid receptor | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Glucocorticoid receptor (NR3C1) has been reported to activate the transcription of SLC22A2 gene in ER(-) breast cancer condition, which leads to an affected expression of the drug transporter Organic cation transporter 2. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GATA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC22A2 gene in megakaryocytes condition | [8] | ||||
TF Protein Name |
Endothelial transcription factor GATA-2 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Endothelial transcription factor GATA-2 (GATA2) has been reported to bind to the transcription of SLC22A2 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Organic cation transporter 2. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
KLF5 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC22A2 gene in gastric cancer condition | [9] | ||||
TF Protein Name |
Krueppel-like factor 5 | Transcription Factor Info | ||||
Affected Drug/Substrate |
metformin | |||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Krueppel-like factor 5 (KLF5) has been reported to activate the transcription of SLC22A2 gene in gastric cancer condition, which leads to an increased expression of the drug transporter Organic cation transporter 2. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
FOXA2 |
Click to Show/Hide to Show 2 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC22A2 gene in health condition | [6] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) has been reported to bind to the transcription of SLC22A2 gene in health condition, which leads to an affected expression of the drug transporter Organic cation transporter 2. | |||||
Transcriptional Phenomenon2 |
Direct binding to SLC22A2 gene | [10] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Colon | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC22A2 gene, which in turn affects the expression or function of the drug transporter Organic cation transporter 2. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC22A2 gene | [11] | ||||
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
Tissue |
Liver; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC22A2 gene, which in turn affects the expression or function of the drug transporter Organic cation transporter 2. | |||||
Class6.3: p53 domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
TP53 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC22A2 gene in health condition | [12] | ||||
TF Protein Name |
Cellular tumor antigen p53 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Cellular tumor antigen p53 (TP53) has been reported to bind to the transcription of SLC22A2 gene in health condition, which leads to an affected expression of the drug transporter Organic cation transporter 2. | |||||
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
RUNX2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC22A2 gene in prostate cancer condition | [13] | ||||
TF Protein Name |
Runt-related transcription factor 2 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Runt-related transcription factor 2 (RUNX2) has been reported to activate the transcription of SLC22A2 gene in prostate cancer condition, which leads to an increased expression of the drug transporter Organic cation transporter 2. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.